Antitrust Body Fines Roche Romania EUR12.8M For Abuse Of Dominant Position On Cancer Drug Market

01.22.2020 By Ecaterina Craciun

Romania’s Competition Council on Wednesday said it fined pharmaceutical company Roche Romania SRL a total RON59,967,944 (EUR12,857,897) for abuse of dominant position on the market of certain cancer medicines in Romania.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: (newsroom), (Marketing & PR), (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

antitrust body
, fine
, Roche Romania
, dominant position
, cancer drugs

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.